STOCKHOLM, October 1, 2015 /PRNewswire/ --
Plans Initial Public Offering on Nasdaq Stockholm in 2016
Pharmalink AB, a specialty pharma company, today announces it has raised SEK100 million (€10.5m / US$12m*) in a mezzanine financing round from all its existing investors,...